The Global Hematology Diagnostics Market size is expected to grow from USD 2.61 billion in 2021, to reach USD 3.89 billion by 2028, with a CAGR of 6.1% for the period of 2021-2028. The North American region dominated the global hematology diagnostics market and accounted for over 48% share of all revenue generated in 2017 due to the increased prevalence of diseases such as leukemia, lymphoma, Hodgkin's disease, and myeloma among adults aged 45 years or above in this region. In addition, countries like China are witnessing an increase in cancer cases which has led to a growing demand for diagnostic equipment used during the diagnosis process for cancer patients throughout Asia Pacific Market.
Hematology Diagnostics can be defined as the process of assessing blood cells and their functions to diagnose, monitor, and manage diseases. It is a branch of clinical pathology that deals with disorders related to red blood cells (erythrocytes), white blood cells (leukocytes), and platelets in the blood. Hematology Diagnostics can be used for diagnosing several types of medical conditions from anemia to leukemia as well as monitoring people who have received chemotherapy treatment or had certain procedures such as x-rays.
On the basis of Type, the market is segmented into Hematology Instruments and Hematology Consumables.
Hematology instruments are designed to perform hematological tests which analyze the quality of blood cells. They typically come in three types: counting, measuring, and analyzing. Counting devices measure a cell’s size and shape while an analysis device will observe changes caused by parasites or malignant growths. One type of instrument is labeled as measurement-analyzing because it does both jobs with different modes for each process.
Hematology consumables consist of a variety of processed materials, including reagents and chemicals, media for culturing bacteria and fungi, buffers, stains, and fixatives. They are used in hematological diagnostic procedures to analyze blood cells or bone marrow samples. Hematology Consumables can be defined as a broad category of items that are used to support the diagnosis and treatment of diseases. These products include blood collection tubes, fluid processing devices, containers for transport media as well as therapeutic agents such as heparin.
On the basis of Application, the market is segmented into Diagnostic Laboratories, Hospitals and Clinics, Academic Institutes, and Others. The diagnostic laboratories segment is expected to dominate the global hematology diagnostics market during the forecast period due to increased demand for more effective methods of blood cell analysis.
The hospitals and clinics segment includes diagnostic laboratories, as well as hospital pharmacies that provide patient care services including hematology diagnostics in addition to other medical specialties such as oncology or cardiology. Other segments include military markets globally who might use this technology during active conflict zones due to its efficiency in detecting hematological disorders.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The European market accounts for the largest share of the global hematology diagnostics market. The Asia Pacific region is expected to witness significant growth in this sector from 2021-2028, owing to the rapid adoption of technology and cost competitiveness.
The Americas hematology diagnostics market is expected to grow at the highest CAGR during the forecast period due to the increased adoption of new diagnostic techniques such as molecular methods for detection in this region. The U.S accounts for the largest share of North America’s hematology diagnostic market due to its favorable reimbursement policies and advanced healthcare infrastructure coupled with increasing prevalence rates of certain diseases that require monitoring like leukemia, myeloma, lymphoma, etc. The growth within this region can also be attributed to continuous advancements being made by pharmaceutical companies pertaining mainly to new drug launches which result in increased sales across all segments under investigation.
The global hematology diagnostics market is projected to grow at a higher pace during the forecast period, primarily driven by factors such as increasing healthcare expenditure and aging population, which has led to an increase in the prevalence of chronic diseases like anemia and leukemia that need regular monitoring with laboratory tests. However, high costs associated with the diagnosis process may pose a challenge for growth in this market. Furthermore, a lack of awareness on erythrocyte sedimentation rate (ESR) testing among physicians can also hinder the growth potential for these products over the assessment period from 2021-2028.
As the global hematology market continues to grow, its segmentation is also undergoing changes. New players are now entering this field with improved technologies and novel testing tools that have been developed in response to changing disease patterns and treatment needs of multidrug-resistant bacteria. As a result, there has been an increase in demand for point-of-care kits (POCT) which can help achieve cost efficiencies through minimally invasive diagnostics. The future of the hematology industry looks promising as it will continue to innovate diagnostic techniques such as advanced molecular assays and automation coupled with higher adoption rates among healthcare facilities across various geographies.
Up Market Research published a new report titled “Hematology Diagnostics Market research report which is segmented by Types (Hematology Instruments, Hematology Consumables), By Applications (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others), By Players/Companies Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche, Beckman Coulter”.
|Report Attributes||Report Details|
|Report Title||Hematology Diagnostics Market Research Report|
|By Type||Hematology Instruments, Hematology Consumables|
|By Application||Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others|
|By Companies||Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche, Beckman Coulter|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||246|
|Number of Tables & Figures||173|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Hematology Instruments, Hematology Consumables and By Application Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others.
Some of the companies that are profiled in this report are:
Hematology Diagnostics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Hematology Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Hematology Diagnostics Market Report:
Some other reports from this category!